DCM
PTCT icon

Dupont Capital Management’s PTC Therapeutics PTCT Stock Holding History

Dupont Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,744
Closed -$690K – 1504
2022
Q3 		$690K Buy
13,744
+5,119
+59% +$251K 0.04% 525
2022
Q2 		$346K Hold
8,625
– – 0.02% 831
2022
Q1 		$322K Sell
8,625
-763
-8% -$29.4K 0.01% 905
2021
Q4 		$374K Sell
9,388
-3,743
-29% -$143K 0.01% 908
2021
Q3 		$489K Sell
13,131
-1,858
-12% -$76.3K 0.02% 881
2021
Q2 		$634K Hold
14,989
– – 0.02% 856
2021
Q1 		$710K Sell
14,989
-3,074
-17% -$183K 0.02% 748
2020
Q4 		$1.1M Sell
18,063
-1,348
-7% -$79.4K 0.02% 515
2020
Q3 		$907K Sell
19,411
-1,301
-6% -$64.1K 0.02% 547
2020
Q2 		$1.05M Sell
20,712
-6,283
-23% -$309K 0.02% 495
2020
Q1 		$1.2M Buy
26,995
+620
+2% +$31.2K 0.03% 402
2019
Q4 		$1.27M Buy
26,375
+8,658
+49% +$368K 0.03% 494
2019
Q3 		$599K Sell
17,717
-1,900
-10% -$82.7K 0.01% 708
2019
Q2 		$883K Buy
19,617
+7,876
+67% +$311K 0.02% 581
2019
Q1 		$442K Hold
11,741
– – 0.01% 805
2018
Q4 		$403K Buy
+11,741
New +$422K 0.01% 808

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dupont Capital Management's PTCT Position: Q4 2022 in Review

Dupont Capital Management sold out of PTC Therapeutics (PTCT) in Q4 2022, closing a stake of 13,744 shares — an estimated $690K sold.

Dupont Capital Management first reported a position in PTCT in Q4 2018 and held it in 16 quarters. The position peaked at $1.27M in Q4 2019. 202 funds tracked by Wall St. Rank hold PTCT as of Q4 2022.

  • Dupont Capital Management reported no remaining PTC Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Dupont Capital Management sold 13,744 PTC Therapeutics shares in Q4 2022, an estimated $690K.
  • Dupont Capital Management first reported a position in PTC Therapeutics in Q4 2018 and held it in 16 quarters.
  • Dupont Capital Management's PTC Therapeutics position peaked at $1.27M in Q4 2019.
  • 202 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2022.

Based on Dupont Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.